ResMed rises after beating quarterly profit estimates

ResMed

25/10/2024 13:31

** Shares of medical device maker ResMed  RMD.N  rise 4.8%
to $250.60 premarket
    ** Late on Thursday, co reported Q1 adj EPS of $2.20,
beating Wall Street estimates of $2.04 - LSEG
    ** RMD's Q1 rev of $1.22 bln was above estimates of $1.18
bln
    ** Up to last close, stock up 39% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))